Porvair appoints Sarah Vawda to its Board as Independent Director

– UK, Kings Lynn –  Porvair plc (LON: PRV) today announced the appointment of Sarah Vawda to its Board as an Independent Non-Executive Director effective from 26 June 2023.

Sarah Vawda will also join the Audit, Remuneration, and Nominations Committees.

About Sarah Vawda

Sarah Vawda is the Senior Independent Non-Executive Director and Chair of the Audit Committee of Access Intelligence plc, an AIM-listed reputation management, marketing and communications, software as a service business; Non-Executive Director of Hamlet Protein A/S, a private equity-backed Danish specialty protein business; and Non-Executive Director and Chair of the Remuneration and Nomination Committees of Noveltech Private Feeds Ltd (India), private equity backed Indian animal nutrition business. She was formerly Non-Executive Director and Chair of the Audit and Risk Committees at Burger King UK; Trustee and Chair of the Audit Committee at The Girls Network; and Governor of the University of Bedfordshire.

Sarah Vawda has previously held senior executive roles within Global multinational companies, including Powergen Plc, Corus Group Plc, Christian Salvesen Plc, Provimi SA, and Johnson Matthey Plc. She qualified as a chartered accountant with PwC.

About Porvair

Porvair is a group of specialist filtration, laboratory, and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial, Laboratory, and Metal Melt Quality.

Source: https://www.porvair.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.